• FluTrackers.com Inc. does not provide medical advice. Information on this web site is collected from various internet resources, and the FluTrackers board of directors makes no warranty to the safety, efficacy, correctness or completeness of the information posted on this site by any author or poster. The information collated here is for instructional and/or discussion purposes only and is NOT intended to diagnose or treat any disease, illness, or other medical condition. Every individual reader or poster should seek advice from their personal physician/healthcare practitioner before considering or using any interventions that are discussed on this website. By continuing to access this website you agree to consult your personal physican before using any interventions posted on this website, and you agree to hold harmless FluTrackers.com Inc., the board of directors, the members, and all authors and posters for any effects from use of any medication, supplement, vitamin or other substance, device, intervention, etc. mentioned in posts on this website, or other internet venues referenced in posts on this website.
  • We are not asking for any donations. Do not donate to any entity who says they are raising funds for us.

Nat Med . A single residue in influenza virus H2 hemagglutinin enhances the breadth of the B cell response elicited by H2 vaccination

tetano

Editor, Senior Moderator
Nat Med


. 2022 Feb 3.
doi: 10.1038/s41591-021-01636-8. Online ahead of print.
A single residue in influenza virus H2 hemagglutinin enhances the breadth of the B cell response elicited by H2 vaccination


Sarah F Andrews[SUP] 1 [/SUP], Julie E Raab[SUP] #[/SUP][SUP] 2 [/SUP], Jason Gorman[SUP] #[/SUP][SUP] 2 [/SUP], Rebecca A Gillespie[SUP] #[/SUP][SUP] 2 [/SUP], Crystal S F Cheung[SUP] #[/SUP][SUP] 2 [/SUP], Reda Rawi[SUP] #[/SUP][SUP] 2 [/SUP], Lauren Y Cominsky[SUP] 2 [/SUP], Jeffrey C Boyington[SUP] 2 [/SUP], Adrian Creanga[SUP] 2 [/SUP], Chen-Hsiang Shen[SUP] 2 [/SUP], Darcy R Harris[SUP] 2 [/SUP], Adam S Olia[SUP] 2 [/SUP], Alexandra F Nazzari[SUP] 2 [/SUP], Tongqing Zhou, Katherine V Houser[SUP] 2 [/SUP], Grace L Chen[SUP] 2 [/SUP], John R Mascola[SUP] 2 [/SUP], Barney S Graham[SUP] 2 [/SUP], Masaru Kanekiyo[SUP] 2 [/SUP], Julie E Ledgerwood[SUP] 2 [/SUP], Peter D Kwong[SUP] 2 [/SUP], Adrian B McDermott[SUP] 3 [/SUP]



Affiliations

Abstract

Conserved epitopes on the influenza hemagglutinin (HA) stem are an attractive target for universal vaccine strategies as they elicit broadly neutralizing antibodies. Such antibody responses to stem-specific epitopes have been extensively characterized for HA subtypes H1 and H5 in humans. H2N2 influenza virus circulated 50 years ago and represents a pandemic threat due to the lack of widespread immunity, but, unlike H1 and H5, the H2 HA stem contains Phe45[SUB]HA2[/SUB] predicted to sterically clash with HA stem-binding antibodies characterized to date. To understand the effect of Phe45[SUB]HA2[/SUB], we compared the HA stem-specific B cell response in post hoc analyses of two phase 1 clinical trials, one testing vaccination with an H2 ferritin nanoparticle immunogen ( NCT03186781 ) and one with an inactivated H5N1 vaccine ( NCT01086657 ). In H2-naive individuals, the magnitude of the B cell response was equivalent, but H2-elicited HA stem-binding B cells displayed greater cross-reactivity than those elicited by H5. However, in individuals with childhood H2 exposure, H5-elicited HA stem-binding B cells also displayed high cross-reactivity, suggesting recall of memory B cells formed 50 years ago. Overall, we propose that a one-residue difference on an HA immunogen can alter establishment and expansion of broadly neutralizing memory B cells. These data have implications for stem-based universal influenza vaccination strategies.
 
Back
Top Bottom